Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Hypersensitivity | 13 | 2021 | 889 | 3.500 |
Why?
|
Desensitization, Immunologic | 14 | 2020 | 483 | 2.620 |
Why?
|
Skin Tests | 18 | 2020 | 611 | 2.450 |
Why?
|
Anaphylaxis | 7 | 2020 | 747 | 1.580 |
Why?
|
Urticaria | 4 | 2019 | 150 | 1.470 |
Why?
|
Candidemia | 1 | 2020 | 29 | 0.750 |
Why?
|
Tetracyclines | 1 | 2020 | 61 | 0.720 |
Why?
|
Allergens | 4 | 2018 | 1308 | 0.640 |
Why?
|
Craniofacial Dysostosis | 1 | 2018 | 73 | 0.630 |
Why?
|
Anti-Bacterial Agents | 5 | 2020 | 7136 | 0.630 |
Why?
|
Cold Temperature | 2 | 2018 | 775 | 0.620 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 296 | 0.590 |
Why?
|
von Willebrand Disease, Type 3 | 1 | 2016 | 5 | 0.580 |
Why?
|
Food Hypersensitivity | 3 | 2018 | 613 | 0.550 |
Why?
|
Pharmaceutical Preparations | 2 | 2021 | 1066 | 0.520 |
Why?
|
Immunoglobulin E | 6 | 2016 | 1461 | 0.460 |
Why?
|
von Willebrand Factor | 1 | 2016 | 666 | 0.430 |
Why?
|
Antibody Specificity | 3 | 2012 | 1096 | 0.420 |
Why?
|
Milk Hypersensitivity | 1 | 2012 | 75 | 0.400 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1513 | 0.390 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1184 | 0.390 |
Why?
|
Cooking | 1 | 2012 | 313 | 0.360 |
Why?
|
Methotrexate | 1 | 2016 | 1711 | 0.360 |
Why?
|
Child | 20 | 2020 | 77033 | 0.270 |
Why?
|
GATA2 Transcription Factor | 1 | 2015 | 158 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9259 | 0.250 |
Why?
|
Cross Reactions | 3 | 2018 | 840 | 0.250 |
Why?
|
Pentobarbital | 1 | 2004 | 155 | 0.240 |
Why?
|
Skin | 1 | 2017 | 4324 | 0.240 |
Why?
|
Phenobarbital | 1 | 2004 | 190 | 0.230 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 163 | 0.210 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 547 | 0.210 |
Why?
|
Immunotherapy | 1 | 2017 | 4391 | 0.200 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2015 | 300 | 0.200 |
Why?
|
Drug Eruptions | 1 | 2004 | 295 | 0.200 |
Why?
|
Echinocandins | 1 | 2020 | 44 | 0.190 |
Why?
|
Clindamycin | 1 | 2018 | 137 | 0.150 |
Why?
|
HLA-B Antigens | 1 | 2018 | 352 | 0.150 |
Why?
|
Adolescent | 11 | 2020 | 85405 | 0.150 |
Why?
|
Tryptases | 1 | 2018 | 190 | 0.150 |
Why?
|
Immunoconjugates | 1 | 2013 | 889 | 0.140 |
Why?
|
Child, Preschool | 10 | 2019 | 40802 | 0.140 |
Why?
|
Food | 2 | 2018 | 760 | 0.140 |
Why?
|
Hypnotics and Sedatives | 1 | 2004 | 1158 | 0.140 |
Why?
|
Humans | 31 | 2021 | 739398 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2020 | 722 | 0.130 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2018 | 278 | 0.130 |
Why?
|
Penicillins | 1 | 2018 | 384 | 0.130 |
Why?
|
Benzyl Alcohol | 1 | 2004 | 5 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2018 | 711 | 0.120 |
Why?
|
Anticonvulsants | 1 | 2004 | 1907 | 0.120 |
Why?
|
Adaptive Immunity | 1 | 2018 | 709 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15036 | 0.110 |
Why?
|
Observer Variation | 1 | 2018 | 2589 | 0.100 |
Why?
|
Egg Hypersensitivity | 1 | 2012 | 44 | 0.100 |
Why?
|
Siblings | 1 | 2016 | 853 | 0.100 |
Why?
|
Vitamin B 12 | 1 | 2004 | 527 | 0.100 |
Why?
|
Hypersensitivity, Immediate | 1 | 2004 | 330 | 0.100 |
Why?
|
Nut Hypersensitivity | 1 | 2010 | 23 | 0.100 |
Why?
|
Eggs | 1 | 2012 | 186 | 0.100 |
Why?
|
Maternal Age | 1 | 2003 | 803 | 0.090 |
Why?
|
Drug Tolerance | 1 | 2012 | 376 | 0.090 |
Why?
|
Infant | 7 | 2018 | 34923 | 0.080 |
Why?
|
Peanut Hypersensitivity | 1 | 2010 | 163 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2277 | 0.080 |
Why?
|
Factor IX | 1 | 1998 | 76 | 0.080 |
Why?
|
Cost of Illness | 1 | 2018 | 1849 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2018 | 2583 | 0.080 |
Why?
|
Medical History Taking | 1 | 2012 | 782 | 0.080 |
Why?
|
Hemophilia B | 1 | 1998 | 80 | 0.080 |
Why?
|
Female | 13 | 2020 | 378853 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2018 | 2950 | 0.070 |
Why?
|
Hot Temperature | 1 | 2012 | 1358 | 0.070 |
Why?
|
Young Adult | 4 | 2020 | 56255 | 0.070 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5632 | 0.070 |
Why?
|
Delivery, Obstetric | 1 | 2003 | 914 | 0.070 |
Why?
|
Male | 12 | 2020 | 349022 | 0.070 |
Why?
|
Physical Examination | 1 | 2012 | 1231 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2018 | 76631 | 0.060 |
Why?
|
Drug Administration Routes | 1 | 2014 | 154 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14740 | 0.060 |
Why?
|
Penicillin G | 1 | 2021 | 42 | 0.050 |
Why?
|
Penicillanic Acid | 1 | 2021 | 44 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13635 | 0.050 |
Why?
|
Adult | 6 | 2020 | 213394 | 0.040 |
Why?
|
Hypersensitivity | 1 | 1998 | 1086 | 0.040 |
Why?
|
Immunization | 2 | 2016 | 1255 | 0.040 |
Why?
|
Dideoxynucleosides | 1 | 2018 | 124 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2014 | 62693 | 0.040 |
Why?
|
Carbamazepine | 1 | 2018 | 229 | 0.040 |
Why?
|
Cefazolin | 1 | 2018 | 96 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 5950 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4935 | 0.030 |
Why?
|
Pruritus | 1 | 2018 | 352 | 0.030 |
Why?
|
Edema | 1 | 2018 | 791 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2018 | 596 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15511 | 0.030 |
Why?
|
Exanthema | 1 | 2018 | 491 | 0.030 |
Why?
|
Infant Welfare | 1 | 2003 | 82 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2004 | 445 | 0.030 |
Why?
|
Reference Standards | 1 | 2016 | 1018 | 0.030 |
Why?
|
Patient Selection | 1 | 2014 | 4211 | 0.020 |
Why?
|
Injections | 1 | 2004 | 837 | 0.020 |
Why?
|
Cocos | 1 | 2010 | 7 | 0.020 |
Why?
|
Risk | 2 | 2016 | 9684 | 0.020 |
Why?
|
Sesamum | 1 | 2010 | 16 | 0.020 |
Why?
|
Middle Aged | 2 | 2020 | 212863 | 0.020 |
Why?
|
Child Welfare | 1 | 2003 | 520 | 0.020 |
Why?
|
Radioallergosorbent Test | 1 | 1998 | 15 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3909 | 0.020 |
Why?
|
Aged | 1 | 2020 | 162698 | 0.020 |
Why?
|
Dermatitis, Atopic | 1 | 2003 | 644 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 2004 | 1177 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3526 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 71974 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13237 | 0.010 |
Why?
|
Quality Improvement | 1 | 2016 | 3730 | 0.010 |
Why?
|
Boston | 1 | 2004 | 9314 | 0.010 |
Why?
|
Odds Ratio | 1 | 2003 | 9846 | 0.010 |
Why?
|
Massachusetts | 1 | 2003 | 8669 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7274 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 25470 | 0.010 |
Why?
|
Logistic Models | 1 | 2003 | 13402 | 0.010 |
Why?
|
United States | 2 | 2016 | 69573 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2003 | 21694 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168368 | 0.000 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_